COVID-19 remains a persistent threat, with recent surges in Asia highlighting the need for continued vigilance. While ...

This update covers the latest health sector developments, including Moderna's COVID-19 vaccine review, GSK's asthma drug FDA ...

What is the JN.1 COVID variant? Know its key symptoms, how fast it's spreading, and whether your vaccine can still protect ...

Zachary Levi said his team informed him that some people in the industry were now unwilling to work with him, though no specific names were given ...

The Food and Drug Administration is adjusting the standard of evidence needed for shots to be approved by the general public.

Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to receive COVID-19 vaccinations. People considered healthy and under the age of 65 ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a ...